The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma

MLA

Imène Hamaidi, et al. The Lim1 Oncogene as a New Therapeutic Target for Metastatic Human Renal Cell Carcinoma. Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8a883a794d857619e87d7da6af8bfaf6&authtype=sso&custid=ns315887.

APA

Imène Hamaidi, Thierry Massfelder, Valérian Dormoy, Hervé Lang, Sylvie Rothhut, Claire Béraud, Mariette Barthelmebs, Véronique Lindner, Nadia Benkirane-Jessel, Sabrina Danilin, & Catherine Coquard. (2019). The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma.

Chicago

Imène Hamaidi, Thierry Massfelder, Valérian Dormoy, Hervé Lang, Sylvie Rothhut, Claire Béraud, Mariette Barthelmebs, et al. 2019. “The Lim1 Oncogene as a New Therapeutic Target for Metastatic Human Renal Cell Carcinoma,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8a883a794d857619e87d7da6af8bfaf6&authtype=sso&custid=ns315887.